Cogent Biosciences (COGT) Net Equity Issued and Repurchased (2017 - 2025)
Cogent Biosciences (COGT) posted quarterly Net Equity Issued and Repurchased of $135.0 million for Q4 2025, up 455.56% quarter-over-quarter from $24.3 million in Q1 2025.
Powered by 
Analysis
Cogent Biosciences (COGT) Net Equity Issued and Repurchased (2017 - 2025) Analysis & Trends
Cogent Biosciences (COGT) has reported Net Equity Issued and Repurchased for 6 consecutive years, with $135.0 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Net Equity Issued and Repurchased changed N/A year-over-year to $135.0 million; the TTM figure through Dec 2025 stood at $159.3 million (down 1.55% YoY), while the FY2025 annual figure was $159.3 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased rose to $135.0 million in Q4 2025 per COGT's latest filing, from $24.3 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $161.8 million in Q2 2023 and bottomed at $24.3 million in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | 141.90 Mn |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | - |
| 10 | Cogent Biosciences | 5.92 Bn | 5.92 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 135.00 Mn |
| Mar 31, 2025 | 24.30 Mn |
| Jun 30, 2023 | 161.80 Mn |
| Dec 31, 2020 | 14.33 Mn |
| Sep 30, 2020 | 10.57 Mn |
| Jun 30, 2020 | 62,000.00 |
| Mar 31, 2020 | 38,000.00 |
| Jun 30, 2019 | 97,000.00 |
| Mar 31, 2019 | 11,000.00 |
| Dec 31, 2018 | 395,000.00 |
| Sep 30, 2018 | 175,000.00 |
| Jun 30, 2018 | 11,000.00 |
| Mar 31, 2018 | 28,000.00 |
| Dec 31, 2017 | 45,000.00 |